tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Argenx price target raised to $820 from $750 at Piper Sandler
PremiumThe FlyArgenx price target raised to $820 from $750 at Piper Sandler
12d ago
Argenx’s Vyvgart Shows Promising Phase III Results, Expanding Market Potential for Seronegative gMG Patients
Premium
Ratings
Argenx’s Vyvgart Shows Promising Phase III Results, Expanding Market Potential for Seronegative gMG Patients
13d ago
Argenx rises 6.0%
Premium
The Fly
Argenx rises 6.0%
13d ago
Argenx price target raised to EUR 700 from EUR 680 at Barclays
PremiumThe FlyArgenx price target raised to EUR 700 from EUR 680 at Barclays
1M ago
Argenx price target raised to EUR 730 from EUR 700 at JPMorgan
Premium
The Fly
Argenx price target raised to EUR 730 from EUR 700 at JPMorgan
1M ago
Argenx price target raised to EUR 655 from EUR 550 at Deutsche Bank
Premium
The Fly
Argenx price target raised to EUR 655 from EUR 550 at Deutsche Bank
1M ago
Argenx price target raised to $880 from $829 at BofA
PremiumThe FlyArgenx price target raised to $880 from $829 at BofA
1M ago
Argenx price target raised to $778 from $708 at Oppenheimer
Premium
The Fly
Argenx price target raised to $778 from $708 at Oppenheimer
1M ago
Argenx price target raised to $788 from $680 at Baird
Premium
The Fly
Argenx price target raised to $788 from $680 at Baird
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100